The in-vitro studies performed in Glauconix's co-culture 3D conventional human outflow model confirm efficacy
Read More3D Human Tissue Retina Vasculature model provides a new and novel approach to rapidly and efficiently screening numerous therapies for diabetic retinopathy and diabetic macular edema.
Read MoreNovaSight has announced that it is running a large, pivotal multi-center randomized controlled trial to assess the safety and effectiveness of an eye-tracking-based treatment for Amblyopia (Lazy Eye).
Read MoreAppointment reflects Glauconix Biosciences' expansion of their 3D Human Tissue model platform within the Ophthalmology space and brings their second commercial model closer to market
Read MorePPT has taken a leadership role in the global eyecare industry by addressing the question, "How much blue light to filter?" It developed and received a Chinese patent for the Glare Reduction Factor (GRF) that measures the efficacy of a computer lens to reduce glare.
Read MoreOcuRing™ is a novel drug delivery platform for cataract surgery with potential to eliminate the need for postoperative topical eye drops. $3M DoD award will fund IND-enabling toxicology and manufacturing activities. LayerBio plans to develop OcuRing™ products for multiple cataract surgery-related indications.
Read MoreeCommerce doesn't replace the value of physical location. Customers are more likely to walk into the store that is powered by eCommerce and vice versa - to buy online when they see that there is a local store behind the website.
Read MoreAmerica's healthcare workers and first responders are putting themselves at risk to help the nation defeat COVID-19. Shamir has partnered with participating optical labs to provide complimentary prescription lens designs for safety eyewear or other lens types for written prescriptions by approved eye care professionals.
Read MoreCurrently operating in 7 countries, including UK with offices in Madrid, Milan, Lisbon, Sao Paulo, Bogotá y Mexico City, CECOP will launch the North American market by 2020.
Read More"Thank you to Capital Access Group and all that helped in this seamless process." - Dr. Craig Bindi, Owner, Laser Eye Center of Silicon Valley
Read MoreEyeKor, Inc., a leading imaging and data management company for the ophthalmic pharmaceutical clinical trial and ocular preclinical laboratory industries, announced today that it is opening a new office in China to enhance EyeKor's capability to provide local support for clinical trial sponsors and sites in China and the APAC region.
Read More